Expertise in
2
conditions

Shimrit Harlev-Ringelstein

Haifa, HA, IL 
Expertise in
2
conditions
Haifa, HA, IL 

Overview

Shimrit Harlev-Ringelstein practices practicing medicine in Haifa, Israel.

Harlev-Ringelstein is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Transplant.

They are actively involved in clinical research, co-authoring 28 peer reviewed articles and participating in 1 clinical trial.

Locations

Haifa, HA, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 2/3, Multicenter Randomized Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (RR DLBCL)
A Phase 2/3, Multicenter Randomized Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (RR DLBCL)
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Drug
Study Drugs: Selinexor, Rituximab, Gemcitabine, Dexamethasone, Cisplatin
Study Phase: Phase 2/Phase 3

28 Total Publications

Safety and outcomes of CD19 CAR-T cell therapy in splenectomized patients with B-cell lymphomas.
Safety and outcomes of CD19 CAR-T cell therapy in splenectomized patients with B-cell lymphomas.
Journal: Transplantation and cellular therapy
Published: April 24, 2026

Frequently Asked Questions about Shimrit Harlev-Ringelstein

Is Shimrit Harlev-Ringelstein a top-rated expert for Chronic Lymphocytic Leukemia (CLL)?

MediFind is an objective health platform that identifies experts based on real-world data. Shimrit Harlev-Ringelstein is classified as an Advanced expert for Chronic Lymphocytic Leukemia (CLL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Shimrit Harlev-Ringelstein participate in research or clinical trials?

Yes. Shimrit Harlev-Ringelstein has published 28 articles and abstracts on conditions like Chronic Lymphocytic Leukemia (CLL). You can view a list of Shimrit Harlev-Ringelstein's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Harlev-Ringelstein's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile